| Gender Preference | None |
| Age Group | 18 - 99 years |
| Research Start Date | September 5, 2012 |
| Research End Date | September 5, 2022 |
| Principal Investigator | Mohammed Milhem, MD |
| Description | Participants in this study have been diagnosed with a type of bone cancer called chondrosarcoma that has spread to other parts of the body or is not able to be removed with surgery. In this study, all subjects will receive the drug pazopanib. This research study is being performed at about 5 clinics across the US. Approximately 47 subjects will take part in this study. |
| Contact Info | Mohammed Milhem, 319-356-2324 |
| Keywords | span itemProp='description'>Bone Cancer ; Cancer ; Chondrosarcoma ; Connective Tissue ; Metastatic Chondrosarcoma ; Milhem ; Neoplasms ; Pazopanib ; Phase 2 ; Phase II ; Sarcoma ; Soft Tissue ; Surgically Unresectable Chondrosarcoma ; |